Brentuximab Intravenous and Diethylpropion Controlled-Release Tablets
Determining the interaction of Brentuximab Intravenous and Diethylpropion Controlled-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brentuximab
Brand name: Adcetris
Synonyms: Brentuximab vedotin, Brentuximab Vedotin
Generic Name: diethylpropion
Brand name: Tenuate, Tenuate Dospan
Synonyms: Diethylpropion
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brentuximab Intravenous-Diethylpropion Extended Release
- Brentuximab Intravenous-Diethylpropion Hydrochloride
- Brentuximab Intravenous-Diethylpropion Tablets
- Brentuximab Intravenous-Difenoxin and Atropine
- Brentuximab Intravenous-Differin
- Brentuximab Intravenous-Differin (Adapalene)
- Diethylpropion Controlled-Release Tablets-Brentuximab vedotin
- Diethylpropion Controlled-Release Tablets-Breo Ellipta
- Diethylpropion Controlled-Release Tablets-Brethine
- Diethylpropion Controlled-Release Tablets-Brethine Subcutaneous
- Diethylpropion Controlled-Release Tablets-Bretylium
- Diethylpropion Controlled-Release Tablets-Bretylium Injection